Namita Thapar has been ruling Shark Tank India with her investments. With her company Emcure, valued at $3 Billion, check out her assets.

Namita Thapar and Anupam Mittal clash on Shark Tank India over work-life balance. Discover their contrasting views on entrepreneurship, employee well-being, and success.

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

Shark Tank India’s Namita Thapar is the latest to join the wave of praise for Aamir Khan’s Sitaare Zameen Par—but her review is more than just admiration. It’s a heartfelt, introspective reflection on ...

Namita Thapar is gearing up for Shark Tank Season 3, revealing her show-stopping look on Instagram. Juggling 25 days a year in this different world, s ...

Namita Thapar, a well-known entrepreneur and a Shark, has been vocal about women's health issues, particularly menopause and perimenopause. Managing a demanding career while dealing with the ...

Namita Thapar from Shark Tank has her style game on lock. From Chanel to Gucci, she knows luxury like the back of her hand. Be it on-screen or off-screen, she serves high-fashion avatars like a pro.

In a recent Reddit AMA (Ask Me Anything) session, Namita Thapar, Executive Director of Emcure Pharmaceuticals and investor on Shark Tank India, addressed comments on her achievements. While also ...

Shark Tank India 2: Namita Thapar's Instagram bio and story were changed to derogatory statements against her. However, she took down the same and issued a clarification for the same.

Namita Thapar and Ashneer Grover have emerged as the biggest investors on Shark Tank India with the highest number of deals closed.

Namita Thapar opened about her struggles with conceiving her second child through IVF. The second season of Shark Tank India has been making headlines ever since it aired on television.

Namita Thapar, the executive director of Emcure Pharmaceuticals and a judge on Shark Tank India, opened up about her struggles with perimenopause.